Related Research Articles
Tissue engineering is a biomedical engineering discipline that uses a combination of cells,engineering,materials methods,and suitable biochemical and physicochemical factors to restore,maintain,improve,or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials,having grown in scope and importance it can be considered as a field of its own.
Peter W. Zandstra,is a Canadian scientist who is the Director of the Michael Smith Laboratories at the University of British Columbia.
Ali Khademhosseini is the CEO of the Terasaki Institute,non-profit research organization in Los Angeles,and Omeat Inc.,a cultivated-meat startup. Before taking his current CEO roles,he spent on year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering,Radiology,Chemical,and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017,he was a professor at Harvard Medical School,and the Wyss Institute for Biologically Inspired Engineering.
The Methuselah Foundation is an American-based global non-profit organization based in Springfield,Virginia,with a declared mission to "make 90 the new 50 by 2030" by supporting tissue engineering and regenerative medicine therapies. The organization was originally incorporated by David Gobel in 2001 as the Performance Prize Society,a name inspired by the British governments Longitude Act,which offered monetary rewards for anyone who could devise a portable,practical solution for determining a ship's longitude.
Shu Chien,is a Chinese–American physiologist and bioengineer. His work on the fluid dynamics of blood flow has had a major impact on the diagnosis and treatment of cardiovascular diseases such as atherosclerosis. More recently,Chien's research has focused on the mechanical forces,such as pressure and flow,that regulate the behaviors of the cells in blood vessels. Chien is currently President of the Biomedical Engineering Society.
Martin L. Yarmush is an American scientist,physician,and engineer known for his work in biotechnology and bioengineering. After spending 4 years as a Principal Research Associate in Chemical Engineering at MIT,in 1988 he joined Rutgers University,where he currently holds the Paul and Mary Monroe Endowed Chair in Science and Engineering and serves as Distinguished Professor of Biomedical Engineering. Yarmush is the founding director of the Center for Engineering in Medicine &Surgery (CEMS) at Massachusetts General Hospital. He is also a Lecturer in Surgery and Bioengineering at Harvard Medical School,and a member of the Senior Scientific Staff at the Shriners Hospital for Children,Boston.
Robert M. Nerem,often referred to as Bob Nerem,a member of the U. S. National Academy of Engineering and the Institute of Medicine,held the Parker H. Petit Distinguished Chair for Engineering in Medicine and Institute Professor Emeritus at the Georgia Institute of Technology where he was an Emeritus Professor until his death.
Angiocrine growth factors are molecules found in blood vessels' endothelial cells that can stimulate organ-specific repair activities in damaged or diseased organs. Endothelial cells possess tissue-specific genes that code for unique growth factors,adhesion molecules and factors regulating metabolism.
Alan J. Russell,is Vice President of Biologics for Amgen,one of the world’s leading Biopharmaceutical companies. Until 2020,Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University. From 2013 through spring of 2016 he was also the Chief Innovation Officer,Allegheny Health Network.
The Fred DeMatteis School of Engineering and Applied Science (SEAS) is the engineering school of Hofstra University,a private university in Hempstead,New York. It was created in 2012 out of the previously existing Departments of Engineering and Computer Science. It is accredited by ABET.
Vsevolod Tkachuk
Akhilesh K. Gaharwar is an Indian academic and an associate professor in the Department of Biomedical Engineering at Texas A&M University. The goal of his lab is to understand the cell-nanomaterials interactions and to develop nanoengineered strategies for modulating stem cell behavior for repair and regeneration of damaged tissue.
Laura E. Niklason is a physician,professor and internationally recognized researcher in vascular and lung tissue engineering. She is the Nicholas M. Greene Professor of Anesthesiology and Biomedical Engineering at Yale University and co-founder,chief executive officer and president of Humacyte,a regenerative medicine company developing bioengineered human tissues.
Rebecca Julia Shipley is a British mathematician and professor of healthcare engineering at University College London (UCL). She is director of the UCL Institute of Healthcare Engineering,co-director of the UCL Centre for Nerve Engineering and Vice Dean (Health) for the UCL Faculty of Engineering Sciences. She is also co-director of the UCL CHIMERA Research Hub with Prof Christina Pagel and a Fellow of the Institution of Engineering and Technology.
Gilda A. Barabino is the president of the Olin College of Engineering,where she is also a professor of biomedical and chemical engineering. Previously,she served as the dean of The Grove School of Engineering at the City College of New York,and as a professor in the Departments of Biomedical Engineering and Chemical Engineering and the CUNY School of Medicine. On March 4,2021,she became the President-Elect of the American Association for the Advancement of Science.
David A. Vorp is an American bioengineer,researcher,entrepreneur,and academic administrator noted for his contributions to aortic aneurysm biomechanics and pathobiology,and tissue engineered vascular grafts. He currently holds the titles of Associate Dean for Research at the University of Pittsburgh Swanson School of Engineering and the John A. Swanson Professor of Bioengineering,with secondary appointments in the departments of Cardiothoracic Surgery,Surgery,Chemical &Petroleum Engineering,and the Clinical &Translational Sciences Institute at the University of Pittsburgh. He also serves as the co-director of the Center for Medical Innovation.,the acting director of the University’s GRID Institute,and the director of the Vascular Bioengineering Laboratory.
Farshid Guilak is an American engineer and orthopedic researcher. He is the Mildred B. Simon Professor of Orthopaedic Surgery at Washington University in St. Louis and director of research at Shriners Hospitals for Children. He is also on the faculty of the departments of Biomedical Engineering,Mechanical Engineering &Materials Science,and Developmental Biology at Washington University.
Anjali Kusumbe is a British-Indian biologist who is the Head of the Tissue and Tumour Microenvironments Group at the Medical Research Council Human Immunology Unit and Weatherall Institute of Molecular Medicine at the University of Oxford. She was awarded the Royal Microscopical Society Award for Life Sciences in 2022.
Tatiana Segura is an American biomedical engineer who is a professor at Duke University. Her research considers biomedical engineering solutions to promote cell growth. She was elected Fellow of the American Institute for Medical and Biological Engineering in 2017 and awarded the Acta Biomaterialia Silver Medal in 2021.
Karen Leigh Christman is an American bioengineer who is the Associate Dean for Faculty Affairs and the Pierre Galletti Endowed Chair for Bioengineering Innovation at University of California,San Diego. Her research considers regenerative medicine and tissue engineering. She was elected a Fellow of the National Academy of Inventors in 2023.
References
- ↑ "From The DeMatteis School of Engineering & Applied Science Dean's Desk". Hofstra University. Retrieved January 5, 2021.
- ↑ Bonfiglio, Briana (2021-06-11). "Hofstra University Breaks Ground on $75M Science and Innovation Center". Long Island Press.
- ↑ "Sina Y. Rabbany Faculty Profile". Hofstra University. Retrieved January 5, 2021.
- ↑ "Blood vessel cells can repair, regenerate organs". ScienceDaily. Retrieved 2021-06-15.
- ↑ "Scientists Engineer Customized Blood Vessels to Support Organ Regeneration and Identification of Cancer Treatments". Weill Cornell Medicine. September 9, 2020. Retrieved January 8, 2021.
- ↑ "Towards Creating Blood Vessels". MIT Technology Review. January 26, 2010. Retrieved January 8, 2021.
- ↑ Pryce, Matthew (12 March 2014). "Dr. Sina Rabbany, Hofstra University - Restoring Damaged Organs". www.wamc.org. Retrieved 2021-06-15.
- ↑ "Sina Y. Rabbany - Google Scholar". scholar.google.com. Retrieved 2021-01-05.
- ↑ Rabbany, Sina (November 1992). "The genesis of intramyocardial pressure". Annals of Biomedical Engineering. 20 (6): 730–731. doi:10.1007/BF02368617. S2CID 32446752 . Retrieved January 6, 2021.
- ↑ Nikic, Joe (March 3, 2016). "Sina Rabbany engineers Hofstra program". The Island Now. Retrieved January 6, 2021.
- ↑ "Dr. Rabbany Continues To Lead SEAS". AIMBE. July 7, 2016. Retrieved January 6, 2021.
- ↑ "Sina Rabbany". ResearchGate. Retrieved January 6, 2021.
- ↑ "College of Fellows, Sina Rabbany" . Retrieved January 5, 2021.
- ↑ "IEEE Long Island Section, 2009 Annual Awards Ceremony" (PDF). Retrieved January 5, 2021.
| International | |
|---|---|
| Academics | |
